Zepbound and Foundayo are registered trademarks of Eli Lilly
Both medications are generally safe when used as prescribed, but they have different risk profiles
That insight is reshaping what success looks like in obesity careand reframing what patients are really seeking when they pursue medication
The American Diabetes Association guidelines support GLP-1 receptor agonist use in patients with diabetic kidney disease, recognizing their cardiovascular and potential renal benefits, but emphasize individualized risk assessment and close follow-up
From there, growth hormone travels to the liver, which in turn produces another key hormone: IGF-1 (insulin-like growth factor 1)
This decline has been proposed as a contributing factor to impaired wound healing, reduced bone density, and loss of skin elasticity observed in older populations